retatrutide dosing phase 2 trial Guide: 1-12 mg Weekly Triple Agonist (2026) Trial Data Dosing Schedule :

Fig.2 Pleiotropic effects of GLP1-RA leading to improvement MASLD/MASH [2] GLP-1RA in MASH Treatment: Clinical Progress Several GLP-1RAs and related agents are currently in various phases of clinical development for MASH treatment [4]

For patients without insurance, we have also partnered with LabCorp to offer a comprehensive lab-panel for a flat-rate of $75

This medication is a compounded product

Its role is to: Enhance insulin secretion when blood sugar rises Reduce glucagon secretion , lowering blood glucose production Slow stomach emptying , which promotes satiety Reduce appetite , leading to weight loss Since natural GLP-1 breaks down quickly, drug companies created synthetic GLP-1 receptor agonists (like semaglutide in Ozempic/Wegovy) that stay active longer

It is backed by ISO 17025-accredited third-party testing and NSF-certified manufacturing